Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Celerity Pharmaceuticals
Illinois, United States
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Celerity Pharmaceuticals focuses on the development and approval of complex generics and specialty drugs, including a bioequivalent doxorubicin (liposomal) for oncology indications and a ready-to-use IV insulin formulation for hospitals, which has attained regulatory approvals in the US, Canada, and EU through partnership with a leading medical products company.[11]
- Therapeutic areas
- OncologyEndocrinology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Partnerships
Major unnamed global pharmaceutical corporation (generic drug collaboration)Capstone Development Services Company
Beyond the preview
Go deeper on Celerity Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Celerity Pharmaceuticals.